We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.21%
2 Consumer Discretionary 7.37%
3 Financials 6.36%
4 Healthcare 5.92%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JMIA
5201
Jumia Technologies
JMIA
$768M
$3K ﹤0.01%
920
-4,100
-82% -$14.8K
KNOP icon
5202
KNOT Offshore Partners
KNOP
$366M
$3K ﹤0.01%
532
+307
+136% +$1.97K
LSBK icon
5203
Lake Shore Bancorp
LSBK
$135M
$3K ﹤0.01%
295
+220
+293% +$2.57K
LUNR icon
5204
Intuitive Machines
LUNR
$2.82B
$3K ﹤0.01%
+273
New +$4K
LYG icon
5205
Lloyds Banking Group
LYG
$90B
$3K ﹤0.01%
1,313
-5,489
-81% -$13.3K
CD
5206
Chaince Digital Holdings
CD
$377M
$3K ﹤0.01%
+2,116
New +$2.35K
MFLX icon
5207
First Trust Exchange-Traded Fund VIII First Trust Flexible Municipal High Income ETF
MFLX
$21.3M
$3K ﹤0.01%
172
-3
-2% -$50
MRKR icon
5208
Marker Therapeutics
MRKR
$18.5M
$3K ﹤0.01%
4,248
+3,603
+559% +$8.57K
MSFU icon
5209
Direxion Daily MSFT Bull 2X ETF
MSFU
$775M
$3K ﹤0.01%
+101
New +$2.44K
MTA
5210
Metalla Royalty & Streaming
MTA
$848M
$3K ﹤0.01%
449
NAII icon
5211
Natural Alternatives International
NAII
$13.6M
$3K ﹤0.01%
286
-496
-63% -$4.46K
FEED
5212
ENvue Medical Inc
FEED
$3.54M
$3K ﹤0.01%
+7
New +$3.77K
NATH icon
5213
Nathan's Famous
NATH
$397M
$3K ﹤0.01%
36
+7
+24% +$518
NEXN
5214
Nexxen International
NEXN
$598M
$3K ﹤0.01%
485
-466
-49% -$3.27K
NINE
5215
DELISTED
Nine Energy Service
NINE
$3K ﹤0.01%
563
-1,229
-69% -$12.7K
NOMD icon
5216
Nomad Foods
NOMD
$1.68B
$3K ﹤0.01%
162
-3,897
-96% -$68.8K
NTIC icon
5217
Northern Technologies International Corp
NTIC
$76.7M
$3K ﹤0.01%
233
+187
+407% +$2.37K
NTR icon
5218
Nutrien
NTR
$32.2B
$3K ﹤0.01%
35
-2,607
-99% -$201K
NUWE icon
5219
Nuwellis
NUWE
$474K
0
NVCT icon
5220
Nuvectis Pharma
NVCT
$627M
$3K ﹤0.01%
250
-1,109
-82% -$11.2K
NWFL icon
5221
Norwood Financial Corp
NWFL
$376M
$3K ﹤0.01%
107
-266
-71% -$8.76K
OFS icon
5222
OFS Capital
OFS
$48.2M
$3K ﹤0.01%
338
-674
-67% -$6.79K
ONCO icon
5223
Onconetix
ONCO
$3.26M
0
ONFO icon
5224
Onfolio Holdings
ONFO
$325K
$3K ﹤0.01%
41
+23
+128% +$2.04K
PLX icon
5225
Protalix BioTherapeutics
PLX
$190M
$3K ﹤0.01%
+1,602
New +$2.81K

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.